StonvexLoading…
StonvexStonvexStonvexCore line items from BRKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.44B | $3.37B | $2.96B | $2.53B |
Operating Income | $68.20M | $253.10M | $436.90M | $432.70M |
Net Income | $-8.60M | $113.10M | $427.20M | $296.60M |
EPS (Diluted) | $-0.15 | $0.76 | $2.90 | $1.99 |
Total Assets | $6.24B | $5.81B | $4.25B | $3.61B |
Total Liabilities | $3.73B | $3.99B | $2.84B | $2.48B |
Cash & Equivalents | $298.80M | $183.40M | $488.30M | $645.50M |
Free Cash Flow OCF − CapEx | $43.30M | $136.00M | $243.20M | $145.20M |
Shares Outstanding | 152.14M | 151.68M | 145.16M | 147.02M |